Clinical trials
Completed Homozygous Familial Hypercholesterolemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 4 |
| Amgen | 3 |
| Novartis Pharmaceuticals | 2 |
| Amryt Pharma | 1 |
| AstraZeneca | 1 |
| Cerenis Therapeutics, SA | 1 |
| Gilead Sciences | 1 |
| Kastle Therapeutics, LLC | 1 |
| Sanofi | 1 |
| The Medicines Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homozygous Familial Hypercholesterolemia | 17 |
| Hyperlipoproteinemia Type II | 6 |
| Hypercholesterolemia | 5 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.